Liminatus Pharma, Inc. (LIMN)
3.78
+0.09
(+2.44%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Total Assets (Quarterly) : 3.404M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.404M |
| March 31, 2026 | 2.790M |
| December 31, 2025 | 0.5128M |
| September 30, 2025 | 1.342M |
| June 30, 2025 | 1.909M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 5.409M |
| September 30, 2024 | 3.068M |
| June 30, 2024 | 3.536M |
| March 31, 2024 | 4.626M |
| December 31, 2023 | 4.502M |
| September 30, 2023 | 4.558M |
| Date | Value |
|---|---|
| June 30, 2023 | 14.72M |
| March 31, 2023 | 14.72M |
| December 31, 2022 | 15.49M |
| September 30, 2022 | 277.45M |
| June 30, 2022 | 276.20M |
| March 31, 2022 | 276.34M |
| December 31, 2021 | 276.44M |
| September 30, 2021 | 276.79M |
| June 30, 2021 | 277.02M |
| March 31, 2021 | 277.44M |
| December 31, 2020 | 0.299M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.103M |
| Shareholders Equity (Quarterly) | 0.3006M |
| Debt to Equity Ratio | 4.799 |
| Current Ratio | 1.116 |
| Net Debt Paydown Yield | -233.3% |